| RS113393517 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS113401862 |
EGLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS113402912 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS113403872 |
PKLR
|
Health Risk |
Pathogenic |
Pyruvate kinase deficiency of red cells, PKLR-related disorder |
| RS113410788 |
SEC23B
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS113413307 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS113413897 |
OSMR
|
Health Risk |
Conflicting classifications of pathogenicity |
OSMR-related disorder, Inborn genetic diseases |
| RS113418909 |
SERPINA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Corticosteroid-binding globulin deficiency, SERPINA6-related disorder |
| RS113418988 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 16, Potassium-aggravated myotonia |
| RS113419388 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS113419658 |
POPDC3
|
Health Risk |
Pathogenic |
Muscular dystrophy, limb-girdle |
| RS113422196 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A3-related disorder |
| RS113422242 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113422365 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS113425529 |
ARHGEF15
|
Health Risk |
Conflicting classifications of pathogenicity |
ARHGEF15-related disorder, Early-infantile DEE |
| RS113425928 |
CERKL
|
Health Risk |
Likely pathogenic |
— |
| RS113432057 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS113434340 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Scapulohumeral muscular dystrophy, Facioscapulohumeral muscular dystrophy 2 |
| RS113436208 |
LMNA
|
Health Risk |
Pathogenic |
Hutchinson-Gilford syndrome, Restrictive dermopathy 2 |
| RS113442895 |
ADCY5
|
Health Risk |
Conflicting classifications of pathogenicity |
ADCY5-related disorder, ADCY5-related disorder |
| RS113443891 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Occipital pachygyria and polymicrogyria, Inborn genetic diseases |
| RS113445400 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCB4-related disorder, ABCB4-related disorder |
| RS113446173 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Wolfram-like syndrome |
| RS113448164 |
HYDIN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 5, HYDIN-related disorder |
| RS113451409 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrest, Cardiovascular phenotype |
| RS113452150 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS113453570 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113460156 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, Malignant hyperthermia |
| RS113462659 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, SCN4A-related disorder |
| RS113464656 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS113467202 |
ESPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113467582 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS113471285 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D |
| RS113472814 |
HPD
|
Health Risk |
Likely pathogenic |
Hawkinsinuria, Tyrosinemia type III |
| RS113473971 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS113474008 |
TGFBR2
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Diabetic retinopathy, Diabetic retinopathy |
| RS113475650 |
AKAP8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113482537 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Autoinflammatory syndrome |
| RS113483303 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 5 |
| RS113483524 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113485015 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS113485686 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS113488022 |
BRAF
|
Health Risk |
Pathogenic |
Carcinoma of colon, Papillary thyroid carcinoma |
| RS113488459 |
DSTYK
|
Health Risk |
Conflicting classifications of pathogenicity |
DSTYK-related disorder, DSTYK-related disorder |
| RS113490514 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS113491328 |
PYCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, PYCR1-related disorder |
| RS113498433 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS113498662 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Inborn genetic diseases |
| RS1135057 |
COL9A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS113506485 |
ITGB6
|
Health Risk |
Conflicting classifications of pathogenicity |
ITGB6-related disorder, Inborn genetic diseases |
| RS1135071 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS113511708 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS11351249 |
NR2E3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive retinitis pigmentosa, Retinitis pigmentosa 37 |
| RS113513162 |
ACTC1
|
Health Risk |
Likely pathogenic |
— |
| RS113513946 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-Related Spectrum Disorders |
| RS113513950 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS113514722 |
REEP6
|
Health Risk |
Pathogenic |
— |
| RS113516368 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS113516976 |
ZBTB24
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Inborn genetic diseases |
| RS113517055 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS113525292 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS113525641 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS113527563 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, KBG syndrome |
| RS113532166 |
ASAH1
|
Health Risk |
Likely pathogenic |
— |
| RS113534264 |
GLB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-B |
| RS1135348 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS113536228 |
RTTN
|
Health Risk |
Conflicting classifications of pathogenicity |
RTTN-related disorder, RTTN-related disorder |
| RS113538343 |
TFPI2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1135401728 |
NGLY1
|
Health Risk |
Likely pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS1135401729 |
NGLY1
|
Health Risk |
Pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS1135401730 |
NGLY1
|
Health Risk |
Likely pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS1135401731 |
NGLY1
|
Health Risk |
Pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation |
| RS1135401732 |
HNRNPU
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1135401733 |
HNRNPU
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Intellectual disability |
| RS1135401734 |
HNRNPU
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1135401735 |
DSP
|
Health Risk |
Likely pathogenic |
Progressive familial heart block, Progressive familial heart block |
| RS1135401736 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 52 |
| RS1135401743 |
HAAO
|
Health Risk |
Pathogenic |
Congenital NAD deficiency disorder, Vertebral |
| RS1135401744 |
KYNU
|
Health Risk |
Pathogenic |
Congenital NAD deficiency disorder, Vertebral |
| RS1135401746 |
GNB1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS1135401747 |
GARS1
|
Health Risk |
Pathogenic |
GARS-associated growth retardation and developmental delay, GARS-associated growth retardation and developmental delay |
| RS1135401749 |
TRAPPC12
|
Health Risk |
Pathogenic |
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome, Progressive childhood encephalopathy |
| RS1135401750 |
INPPL1
|
Health Risk |
Pathogenic |
Opsismodysplasia, Opsismodysplasia |
| RS1135401752 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS1135401753 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS1135401754 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1135401755 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1135401756 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1135401757 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1135401758 |
TUBB2B
|
Health Risk |
Likely pathogenic |
Complex cortical dysplasia with other brain malformations 7, Complex cortical dysplasia with other brain malformations 7 |
| RS1135401759 |
PLP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS1135401760 |
TBL1XR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 41 |
| RS1135401761 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1135401762 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS1135401763 |
CHD8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS1135401764 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1135401765 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, See cases |
| RS1135401766 |
MED13L
|
Health Risk |
Pathogenic |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS1135401767 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS1135401768 |
SIN3A
|
Health Risk |
Pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |